Silent Kidney Disease Threatens Global Health

Chronic kidney disease (CKD) is a silent global health crisis, with 30% to 50% of cases remaining undiagnosed even in wealthier nations. This progressive condition, where kidneys lose function, is currently the ninth leading cause of death globally and is projected to become the fifth by 2040.

Many individuals are unaware they have CKD until it reaches an advanced stage, necessitating dialysis or transplantation. Researchers emphasize that simple urine tests for protein, alongside blood tests and blood pressure checks, can facilitate early diagnosis. Early intervention is key to slowing or preventing disease progression.

The disease disproportionately affects women and non-white ethnic groups, who are more likely to remain undiagnosed. Leading risk factors include diabetes, hypertension, obesity, and cardiovascular disease, with risk increasing with age.

Greater investment in screening, laboratory capacity, and healthcare systems, especially in low- and middle-income countries, is urgently needed. Advances in biomarkers, genetic testing, and therapies offer hope for delaying progression when treatment begins early.